WOLFENBUTTEL, Germany & BEVERLY, Mass.--(BUSINESS WIRE)--BIOBASE announced today that it has joined the Affymetrix GeneChip-compatible Applications Program, and its ExPlain™ Analysis System and TRANSFAC® database has achieved GeneChip-compatible™ status with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform. As a GeneChip-compatible software provider, BIOBASE is committed to seamlessly integrating its applications with the Affymetrix GeneChip platform.